Back to SYRE

Remedium Capital Partners, LLC → SYRE

Remedium Capital Partners, LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$103.3M
Q3 2026
Peak value
$130M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$47.7M
Q1 2026$96.2M
Q1 2026$73.5M
Q2 2026$130M
Q3 2026$103.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$103.3M1.16M——
Q2 2026$130M1.46M——
Q1 2026$73.5M1.46M——
Q1 2026$96.2M1.91M——
Q4 2025$47.7M1.46M——

Other funds holding SYRE

Other Remedium Capital Partners, LLC positions

ORKA

Oruka Therapeutics Inc

$149M
ORKA

Oruka Therapeutics Inc

$92.7M
ORKA

Oruka Therapeutics Inc

$79.5M
APGE

Apogee Therapeutics Inc

$77.9M
ORKA

Oruka Therapeutics Inc

$76.8M
APGE

Apogee Therapeutics Inc

$49.1M
APGE

Apogee Therapeutics Inc

$49.1M
ORKA

Oruka Therapeutics Inc

$47.1M